Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation

NCT06013033 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT06013033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06013033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock